# Early Use of Botulinum Toxin in Spasticity Post Stroke.

Study · id `cardio:ct-nct01882556` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01882556](<https://clinicaltrials.gov/study/NCT01882556>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01882556

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01882556. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01882556, source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01882556, source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01882556, source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)
- Completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01882556, source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01882556, source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01882556-2014-11-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Use of Botulinum Toxin in Spasticity Post Stroke.
- Acronym: EUBoSS
- Condition: Stroke
- Condition: Muscle Spasticity
- Condition: Contracture
- Intervention (Drug): onabotulinumtoxinA
- Intervention (Drug): Placebo
- Lead sponsor: Sandwell & West Birmingham Hospitals NHS Trust
- Lead sponsor class: OTHER
- Collaborator: Keele University
- Collaborator class: OTHER
- Collaborator: Stroke Research Network
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial (`cardio:pubmed-33040610`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial (`cardio:pubmed-36325678`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d9612b5e26fe467c02b09e06dba66430bfbac78608bbe9526c83b943e0f41712
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
